维普期刊资源整合服务平台（V6.5）

194篇 您的检索式：作者名="Ravdin"

选中清除导出查看参考文献查看引证文献引用追踪共10页首页上一页第1页下一页末页 /10 跳转

	题名	作者	年代	出处	被引量
1	Ki67 in breast cancer: prognostic and predictive potential显示文摘	Rinat Yerushalmi Ryan Woods Peter M Ravdin Malcolm M Hayes Karen A Gelmon	2010	Lancet Oncology2010，，2：	4
2	他莫昔芬辅助化疗治疗乳腺癌的疗效及给药时机研究显示文摘背景及目的:他莫昔芬是绝经后激素受体阳性的乳腺癌妇女的标准辅助治疗药物,本研究评价了他莫昔芬联合化疗的疗效,探讨他莫昔芬的给药时机与化疗同步或者序贯。	Albain KS Barlow WE Ravdin PM	2009	中国处方药2009，8，12：	2
3	Overview of randomized trials of systemic adjuvant therapy显示文摘		2000	Cancer Treat Res2000，103，：	1
4	Adjuvant chemohormonal therapy for primary breast cancer should be sequential instead of concurrent:initial results from intergroup trial 0100 (SWOG-8814)显示文摘	Albain KS Green S J Ravdin PM	2002	Proc Am Soc Clin Oncol2002，21，：	1
5	Phase Ⅱ trial of docetaxel in advanced anthraxcycline-resistant or anthraxcenedione-resistant breast cancer 显示文摘	Ravdin PM Burris HA Ⅲ Cook G	1995	J Clin Oncol1995，13，12：	1
6	Computer program to assist in making decisions about adjuvant therapy for women with early breast cancer 显示文摘	Ravdin PM Siminoff LA Davis GJ	2001	J Clin Oncol2001，19，4：	1
7	Time-dependence of hazard ratios for prognostic factors in primary breast cancer显示文摘	HILSENBECK S G RAVDIN P M DE MOOR C A	1998	Breast Cancer Res Treat1998，52，13：	1
8	2000 update of recommendations for the use of tumor markers in breast and colorectal cancer: clinical practice guidelines of the American Society of Clinical Oncology显示文摘	Bast RC Jr Ravdin P Hayes DF	2001	J Clin Oncol2001，19，6：	1
9	Population-based validation of the prognostic model ADJUVANT! for early breast cancer 显示文摘	Olivotto IA Bajdik CD Ravdin PM	2005	J Clin Oncol2005，23，12：	1
10	CMF versus CAF with and without tamoxifen in high risk node negative breast cancer patients and a natural history follow-up study in low risk node negative patients: first results of Intergroup trial in 0102 显示文摘	Hutchins L Green S Ravdin P	1998	Proc Am Soc Clin Oncol1998，17，：	1
11	Ki-67 in Breast Cancer: Prognostic and Predictive Potential显示文摘	Yemshalmi R Woods R Ravdin PM	2010	Lancet Oncol2010，11，2：	1
12	Features of gait most responsive to tap test in normal pressure hydrocephalus显示文摘	Ravdin LD Katzen HL Jackson AE		0，，05：	1
13	2000 update of recommen- dations for the use of tumor markers in breast and colorectal can- cer:clinical practice guidelines of the American Society of Clini- cal Oncology显示文摘	Bast RC Jr Ravdin P Hayes DF	2001	J Clin Oncol2001，19，6：	1
14	The c-erbB-2 proto-oncogene as a prognos- tic and predictive marker in breast cancer: a paradigm for the devel- opment of other macromolecular markers--a review显示文摘	Ravdin PM Chamness GC	1995	Gene1995，159，1：	1
15	CMF versus CAF with and without tamoxifen in high risk node negative breast cancer patient and a natural history follow-up study in low risk node negative patients:first results of intergroup trial in 0102 显示文摘	Hutchins L Green S Ravdin P	1998	Proc Am Soc Clin Oncol1998，17，：	1
16	The cerbB-2 proto-oncogene as a prognostic and predictive marker in breast cancer: a paradigm for the development of other macromolecular marker-a review显示文摘	Chamness GC	1995	Gene1995，159，：	1
17	Adjuvant che- mohormonal therapy for primary breast cancer should be se- quential instead of concurrent: initial results from intergroup trial 0100 (SWOG-8824) 显示文摘	Albain K S Green S J Ravdin P M	2002	Proc Am Soc Clin Oncol2002，2，1：	1
18	A computer program to assist in making breast cancer adjuvant therapy decision显示文摘		1996	Semin Oncol1996，23，2：	1
19	Time-dependence of hazard ratios for prognostic factors in primary breast cancer显示文摘	Hilsenbeck SG Ravdin PM de Moor CA	1998	Breast Cancer Res Treat1998，52，13：	1
20	Ki67 in breast cancer: prognostic and predictive potential显示文摘	YERUSHALMI R WOODS R RAVDIN P M	2010	Lancet On- col2010，11，2：	1

返回顶部每页显示：

共10页首页上一页第1页下一页末页 /10 跳转

互联网出版许可证新出网证(渝)字10号全国400电话 - 免长途话费

用户提示